Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in man. 1981

F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati

The effects of different doses of D-sulpiride (1, 6, 12 and 25 mg, i.v.) on arterial blood pressure (ABP), heart rate (HR) and prolactin (PRL), growth hormone (GH), insulin and gastrin secretions have been studied in 8 normal men. D-Sulpiride increased systolic ABP with a maximum effect rather 12 mg i.v., while it had only slight effects on diastolic ABP and HR. PRL secretion was increased by D-sulpiride in a dose-dependent way, while insulin secretion was lowered and GH secretion slightly enhanced only in a restricted range of doses (6 mg and 12 mg i.v., respectively). Gastrin secretion seemed to be unaffected by D-sulpiride at any of the tested doses. These results are discussed in view of a possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in contrast with the relatively pure antagonistic action of the levo isomer.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
January 1982, General pharmacology,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
October 2000, European journal of pharmacology,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
January 1988, Journal of neural transmission,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
April 1989, European journal of pharmacology,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
April 2001, The Journal of pharmacology and experimental therapeutics,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
September 2017, Journal of pharmaceutical sciences,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
October 1994, Agents and actions,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
December 1992, Behavioural pharmacology,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
January 1983, Contemporary anesthesia practice,
F Benfenati, and P Bernardi, and P Cortelli, and M Capelli, and C Adani, and L Calzà, and L F Agnati
December 1998, European journal of pharmacology,
Copied contents to your clipboard!